Biovail Corporation
Records under this name other than patents Biovail Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,676,966 | Extended Release Metformin Hydrochloride Formulations Formerly held Term ended Ended no later than Nov 10, 2021 · Medium confidence | Term ended | Ended no later than Nov 10, 2021 | Medium confidence |
| US 6,033,686 | Controlled release tablet of bupropion hydrochloride Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,165,512 | Dosage forms containing taste masked active agents Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,312,724 | Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof Formerly held Term ended Term ended Apr 3, 2018 · USPTO record | Term ended | Term ended Apr 3, 2018 | USPTO record |
| US 6,893,661 | Controlled release formulations using intelligent polymers Formerly held Term ended Term ended Apr 3, 2018 · USPTO record | Term ended | Term ended Apr 3, 2018 | USPTO record |
| US 6,417,886 | Image transmission apparatus and method and image transmission system Formerly held Term ended Term ended Feb 20, 2018 · USPTO record | Term ended | Term ended Feb 20, 2018 | USPTO record |
| US 6,967,218 | Pravastatin Pharmaceutical Formulations and Methods of Their Use Formerly held Lapsed on the fee record Ended Nov 22, 2017 · High confidence | Lapsed on the fee record | Ended Nov 22, 2017 | High confidence |
| US 6,517,886 | Positive hydration method of preparing confectionery and the resulting product Formerly held Term ended Ended no later than Jun 24, 2017 · USPTO record | Term ended | Ended no later than Jun 24, 2017 | USPTO record |
| US 6,509,037 | Sustained Release Pharmaceutical Matrix Tablet of Pharmaceutically Acceptable Salts of Diclofenac and Process for Preparation Thereof Formerly held Lapsed on the fee record Ended Jan 21, 2015 · Medium confidence | Lapsed on the fee record | Ended Jan 21, 2015 | Medium confidence |
| US 6,733,789 | Multiparticulate bisoprolol formulation Formerly held Lapsed on the fee record Ended May 11, 2012 · USPTO record | Lapsed on the fee record | Ended May 11, 2012 | USPTO record |